1. Molecular determinants of response to matuzumab in combination with paclitaxel for patients with advanced non-small cell lung cancer
   Marcus M. Schittenhelm et al, 2009, Molecular Cancer Therapeutics CrossRef
2. Ceramide Analog 5cc Overcomes TRAIL Resistance by Enhancing JNK Activation and Repressing XIAP Expression in Metastatic Colon Cancer Cells
   Qiqian Huang et al, 2023, Chemotherapy CrossRef